Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001719879 | SCV000209752 | likely benign | not provided | 2018-05-25 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24728327, 26976419, 25480502) |
Ambry Genetics | RCV000159738 | SCV000214670 | likely benign | Hereditary cancer-predisposing syndrome | 2018-07-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000550304 | SCV000622617 | benign | Ataxia-telangiectasia syndrome | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000159738 | SCV000910886 | benign | Hereditary cancer-predisposing syndrome | 2016-12-07 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149822 | SCV003837811 | likely benign | Breast and/or ovarian cancer | 2021-09-21 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000120146 | SCV004027246 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001719879 | SCV004133260 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | ATM: BP4, BS2 |
Breakthrough Genomics, |
RCV001719879 | SCV005218458 | likely benign | not provided | criteria provided, single submitter | not provided | ||
ITMI | RCV000120146 | SCV000084287 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Department of Pathology and Laboratory Medicine, |
RCV001355719 | SCV001550676 | likely benign | Malignant tumor of breast | no assertion criteria provided | clinical testing | ATM, EXON38, c.5693G>A, p.Arg1898Gln, Heterozygous, Likely BenignrnThe ATM p.Arg1898Gln variant was identified in 2 of 7928 proband chromosomes (frequency: 0.0003) from individuals with breast or thyroid cancer and was present in 1 of 1362 control chromosomes (frequency: 0.0007) from healthy individuals (Tung 2016, Yehia 2018, Bodian 2014). The variant was identified in dbSNP as “with likely benign allele” and in ClinVar (classified as likely benign by Invitae and 2 other submitters; and as benign by Color). The variant was identified in control databases in 80 of 245,810 chromosomes (2 homozygous) at a frequency of 0.0003, increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: South Asian in 68 of 30772 chromosomes (freq: 0.002), Latino in 3 of 33,538 chromosomes (freq: 0.00009) and European in 9 of 111,452 chromosomes (freq: 0.00008), but not in the African, Other, Ashkenazi Jewish, East Asian, or Finnish populations. The p.Arg1898 residue is conserved in mammals but not in more distantly related organisms, although computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. | |
Prevention |
RCV004551179 | SCV004772508 | likely benign | ATM-related disorder | 2020-11-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |